Stock screener

SPTX

Broke outConviction 53LongHealthcareScan · Mon, Aug 10, 2026
Symmetrical triangletriangle
SPTX$23.00-2.65%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 95.83K
May 11May 28Jun 16Jul 6Jul 23Aug 10

Trade plan

LongReward : Risk0.43
Entry
Entry
23.00
Risk
Stop
19.54
-15.0% to stop
Reward
Target 1
24.48
+6.4% to target
Stretch
Target 2
25.96
+12.9% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Seaport Therapeutics, Inc.Biotechnologywww.seaporttx.com
Price23.00
Change-2.65%
Gap-2.29%
Rel volume0.66×
Avg volume103.57K
Avg $ vol2.18M
SMA 2021.11
SMA 5019.76
SMA 200
Price vs 50+16.37%
Price vs 200
MA stack
50/200 cross
Supertrendup · 19.51
RSI (14)62
MACD hist0.23
MACD crossbull · 3d
Stoch %K / %D71 / 83
ADX (14)17
+DI / −DI25 / 14
RSI divergence
MACD divergenceBearish
ATR %+6.59%
ADR %6.83%
52w high23.62
52w low15.25
From 52w high-2.65%
Above 52w low+50.79%
New 52w highNo
SqueezeFired
Bollinger width21.12%
%B0.92
Donchian pos71.42%
Donchian high24.57
Donchian low19.06
AVWAP (52w high)23.46
vs AVWAP high-1.96%
AVWAP (52w low)18.33
vs AVWAP low+25.43%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d0.66×
Avg vol (14d)95.83K
Avg vol (20d)103.57K
Avg $ vol (20d)2.18M
Market cap1.23B
RS 3m (vs SPY)+46.69%
RS 6m (vs SPY)
RS line new highYes
Trend template
Technical rank86.9
1 week+11.36%
1 month+6.56%
3 months+43.27%
6 months
1 year
YTD+15.90%
P/E
P/B2.91
P/S
P/FCF
EPS
Div yield
ROE
ROA
Debt/Eq
Current18.00
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth
Price target38.40
Target upside66.99%
Analyst ratingBuy
Institutional8.26%
Ent. value1.17B
Revenue
Net income-62.6M
Gross profit
Free cash flow
IndustryBiotechnology
ExchangeNasdaq
Shares out53.53M
Employees
ListedFri, May 1, 2026
Free float28.22M
Float %52.7%
Short interest1.98M
Days to cover12.3d
Short volume72.4%
Squeeze score59 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.78 vs −$0.71
Last surprise-150.7% miss
Setup gradeC
Conviction53 / 100
Pattern quality47%
Tech rank86.9 / 100
Group rank86 / 100 · Leading
Status laneBroke out
Setup directionLong
Pattern familyTriangle
Resistance22.20
Support19.92
Days since event3d
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 44 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Aug 5
    1 scan
  2. Broke out
    Aug 6 – Aug 10
    3 scans

Congress activity

Disclosed STOCK Act trades in SPTX

All disclosures →
No recent disclosed trades by Congress in SPTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPTX · 4 buys · 6 sells

InsiderSideShares
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert2.68M
PureTech LYT, Inc.
10% owner · Series A-2 Preferred Stock · 2026-05-04
Convert8.42M
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert965.25K
PureTech LYT, Inc.
10% owner · Series B Preferred Stock · 2026-05-04
Convert3.03M
PureTech LYT, Inc.
10% owner · Series A-1 Preferred Stock · 2026-05-04
Convert40M
PureTech Health plc
10% owner · Series A-1 Preferred Stock · 2026-05-04
Convert40M
PureTech Health plc
10% owner · Series A-2 Preferred Stock · 2026-05-04
Convert8.42M
PureTech Health plc
10% owner · Series B Preferred Stock · 2026-05-04
Convert3.03M
PureTech LYT, Inc.
10% owner · Common Stock · 2026-05-04
Convert12.74M
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert12.74M

SEC filings

EDGAR filings in SPTX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.